NCT00458536 Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF Status COMPLETED Phase PHASE1/PHASE2
NCT00458237 Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00456885 The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women Status COMPLETED Phase PHASE4
NCT00455897 CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE2
NCT00441142 Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00436072 ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00434980 Family-Directed Cognitive Adaptation Program for Individuals With Schizophrenia Status COMPLETED Phase NA
NCT00428012 Quality of Life Therapy for Adults With ESRD Awaiting Renal Transplantation Status COMPLETED Phase PHASE2/PHASE3
NCT00425815 Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia Status WITHDRAWN Phase PHASE2
NCT00421252 Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization. Status TERMINATED Phase PHASE4
NCT00409292 RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00378105 Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT00366457 Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer Status COMPLETED Phase PHASE2